diuretics

Summary

Summary: Agents that promote the excretion of urine through their effects on kidney function.

Top Publications

  1. ncbi Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Barry R Davis
    The University of Texas School of Public Health, Houston, TX 77030, USA
    Circulation 113:2201-10. 2006
  2. ncbi Diuretics: still essential drugs for the management of hypertension
    Flavio Danni Fuchs
    Servico de Cardiologia, Hospital de Clinicas de Porto Alegre, Ramiro Barcelos, 2350, 90 035 903, Porto Alegre, RS, Brazil
    Expert Rev Cardiovasc Ther 7:591-8. 2009
  3. ncbi Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    Michael R Bristow
    Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    N Engl J Med 350:2140-50. 2004
  4. ncbi Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
    Henry R Black
    Rush Medical College of Rush University, Chicago, IL 60612, USA
    JAMA 289:2073-82. 2003
  5. ncbi Reappraisal of the role of diuretics in heart failure
    Maya Guglin
    University of South Florida, Tampa, USA
    Cardiol Rev 17:56-9. 2009
  6. ncbi Hydrochlorothiazide versus chlorthalidone in the management of hypertension
    Kimberly M Neff
    New Mexico VA Health Care System, Albuquerque, NM, USA
    Cardiol Rev 18:51-6. 2010
  7. ncbi Thiazide diuretics exacerbate fructose-induced metabolic syndrome
    Sirirat Reungjui
    Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, USA
    J Am Soc Nephrol 18:2724-31. 2007
  8. ncbi The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction
    G W K Yip
    Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR
    Heart 94:573-80. 2008
  9. ncbi Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators
    P S Sever
    Imperial College School of Medicine, London, UK
    J Hypertens 19:1139-47. 2001
  10. ncbi Treatment of hypertension in patients 80 years of age or older
    Nigel S Beckett
    Care of the Elderly, Division of Medicine, Imperial College London, United Kingdom
    N Engl J Med 358:1887-98. 2008

Research Grants

  1. CELLULAR CALCIUM TRANSPORT IN URINARY EPITHELIA
    Peter Friedman; Fiscal Year: 2003
  2. Hypertension Pharmacogenetics
    Julie Johnson; Fiscal Year: 2006
  3. RISK FACTORS FOR VERTEBRAL FRACTURE AND BONE LOSS
    Douglas Kiel; Fiscal Year: 1993
  4. Pharmacogenetics and Cardiovascular Events
    Bruce Psaty; Fiscal Year: 2006
  5. REGULATION OF KIDNEY-SPECIFIC GENE EXPRESSION
    Peter Igarashi; Fiscal Year: 1999
  6. A Family Partnership Intervention for Heart Failure
    Sandra Dunbar; Fiscal Year: 2009
  7. REGULATION OF KAPPA OPIOID RECEPTORS
    Lee Yuan Liu Chen; Fiscal Year: 2002
  8. Cellular Pharmacology of Kappa Opioid Receptor
    Lee Yuan Liu Chen; Fiscal Year: 2007
  9. Combined Computational and Wet Lab Screening for Drugs Tested via OATs
    Sanjay K Nigam; Fiscal Year: 2010
  10. CHARACTERIZATION OF INTESTINAL ABSORPTION OF VITAMIN B1
    HAMID SAID; Fiscal Year: 2003

Detail Information

Publications276 found, 100 shown here

  1. ncbi Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Barry R Davis
    The University of Texas School of Public Health, Houston, TX 77030, USA
    Circulation 113:2201-10. 2006
    ..The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) stipulated assessment of the relative effect of chlorthalidone, lisinopril, and amlodipine in preventing HF...
  2. ncbi Diuretics: still essential drugs for the management of hypertension
    Flavio Danni Fuchs
    Servico de Cardiologia, Hospital de Clinicas de Porto Alegre, Ramiro Barcelos, 2350, 90 035 903, Porto Alegre, RS, Brazil
    Expert Rev Cardiovasc Ther 7:591-8. 2009
    According to most current international guidelines for hypertension, diuretics are indicated for elderly and black patients, unless they have any of a long list of other preferential indications...
  3. ncbi Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    Michael R Bristow
    Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    N Engl J Med 350:2140-50. 2004
    ....
  4. ncbi Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
    Henry R Black
    Rush Medical College of Rush University, Chicago, IL 60612, USA
    JAMA 289:2073-82. 2003
    ..Hypertensive patients are often given a calcium antagonist to reduce cardiovascular disease risk, but the benefit compared with other drug classes is controversial...
  5. ncbi Reappraisal of the role of diuretics in heart failure
    Maya Guglin
    University of South Florida, Tampa, USA
    Cardiol Rev 17:56-9. 2009
    The focus of this review is to explore the controversy between the broad acceptance of loop diuretics as a first-line treatment for heart failure (HF) and the data regarding their association to increased morbidity and mortality in HF...
  6. ncbi Hydrochlorothiazide versus chlorthalidone in the management of hypertension
    Kimberly M Neff
    New Mexico VA Health Care System, Albuquerque, NM, USA
    Cardiol Rev 18:51-6. 2010
    Thiazide diuretics are a mainstay for the treatment of hypertension...
  7. ncbi Thiazide diuretics exacerbate fructose-induced metabolic syndrome
    Sirirat Reungjui
    Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, USA
    J Am Soc Nephrol 18:2724-31. 2007
    ..Thiazide diuretics are frequently used in these patients for treatment of hypertension, but they also exacerbate metabolic syndrome...
  8. ncbi The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction
    G W K Yip
    Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR
    Heart 94:573-80. 2008
    ..The effect of renin-angiotensin blockade by irbesartan or ramipril in combination with diuretics on quality of life (QoL), regional and global systolic and diastolic function was assessed in HFNEF patients.
  9. ncbi Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators
    P S Sever
    Imperial College School of Medicine, London, UK
    J Hypertens 19:1139-47. 2001
    ..To test a second primary hypothesis that a statin compared with placebo will further protect against CHD endpoints in hypertensive subjects with a total cholesterol < or = 6.5 mmol/l...
  10. ncbi Treatment of hypertension in patients 80 years of age or older
    Nigel S Beckett
    Care of the Elderly, Division of Medicine, Imperial College London, United Kingdom
    N Engl J Med 358:1887-98. 2008
    ..Whether the treatment of patients with hypertension who are 80 years of age or older is beneficial is unclear. It has been suggested that antihypertensive therapy may reduce the risk of stroke, despite possibly increasing the risk of death...
  11. ncbi Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide
    Patrícia Guerrero
    Graduate Study Program in Health Sciences Cardiology, Universidade Federal do Rio Grande do Sul UFRGS, Brazil
    Clin Exp Hypertens 30:553-64. 2008
    ..Cough, albeit predominantly mild, was reported more frequently by participants treated with enalapril. We conclude that enalapril is more effective than amiloride to lower BP of patients on hydrochlorothiazide with uncontrolled BP...
  12. ncbi Risk factors for thiazide-induced hyponatraemia
    K M Chow
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, China
    QJM 96:911-7. 2003
    ..factors for thiazide-induced hyponatraemia, but gender, duration of thiazide use, concomitant therapy with loop diuretics, angiotensin-converting enzyme inhibitors or non-steroidal anti-inflammatory drugs, and renal function were not...
  13. ncbi Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
    M J Brown
    Clinical Pharmacology Unit, University of Cambridge, UK
    Lancet 356:366-72. 2000
    The efficacy of antihypertensive drugs newer than diuretics and beta-blockers has not been established...
  14. ncbi Gout, diuretics and the kidney
    E Pascual
    Ann Rheum Dis 65:981-2. 2006
  15. ncbi Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides
    Claudiu T Supuran
    Universita degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Rm 188, Via della Lastruccia 3, I 50019 Sesto Fiorentino Firenze, Italy
    Curr Pharm Des 14:641-8. 2008
    The widely clinically used benzothiadiazines and high ceiling diuretics, such as hydrochlorothiazide, hydroflumethiazide, quinethazone, metolazone, chlorthalidone, indapamide, furosemide and bumetanide, contain SO(2)NH(2) moieties acting ..
  16. ncbi Antihypertensive therapies
    Richard E T Smith
    Nat Rev Drug Discov 6:597-8. 2007
  17. ncbi Interactions of human organic anion transporters with diuretics
    Habib Hasannejad
    Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, Japan
    J Pharmacol Exp Ther 308:1021-9. 2004
    The tubular secretion of diuretics in the proximal tubule has been shown to be critical for the action of drugs...
  18. ncbi Very-low-dose combination: a first-line choice for the treatment of hypertension?
    Bernard Waeber
    Division of Clinical Pathophysiology, University Hospital, BH 19, 1011 Lausanne, Switzerland
    J Hypertens Suppl 21:S3-10. 2003
    ..This is, for instance, the case for diuretics, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II type 1 (AT1) receptor antagonists ..
  19. ncbi Current usage of diuretics among hypertensive patients in Japan: the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study
    Kayo Murai
    Department of Planning for Drug Development, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan
    Hypertens Res 29:857-63. 2006
    ..Measurement Evaluation (J-HOME) study, we examined the current situation with respect to the prescription of diuretics, including the prevalence of diuretic treatment and the dosages used for patients with essential hypertension in ..
  20. ncbi Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study
    Cristina Giglioli
    Department of Heart and Vessels, Viale Morgagni, 85, Florence, Italy
    Eur J Heart Fail 13:337-46. 2011
    To evaluate the clinical, biohumoral, and haemodynamic effects of ultrafiltration vs. intravenous diuretics in patients with decompensated heart failure (HF)...
  21. ncbi Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure
    F Braunschweig
    Department of Cardiology, Karolinska Hospital, Stockholm, Sweden
    Eur Heart J 23:59-69. 2002
    ..Such data provide useful information for tailoring an optimal diuretic dose in patients with congestive heart failure...
  22. ncbi Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study
    Salvatore Paterna
    Department of Emergency Medicine, University of Palermo, Palermo, Italy
    J Am Coll Cardiol 45:1997-2003. 2005
    ..CONCLUSIONS: Our data show that the HSS group reached dry weight more rapidly, a significantly faster reduction in BNP levels, shorter hospitalization stay, and lower incidence in readmissions in the 30-day study period...
  23. ncbi Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department
    W Frank Peacock
    Department of Emergency Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Rev Cardiovasc Med 3:S41-8. 2002
    ....
  24. ncbi Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy
    Pantelis A Sarafidis
    Section of Nephrology and Hypertension, 1st Department of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, St Kiriakidi 1, 54636, Thessaloniki, Greece
    Expert Opin Drug Saf 9:259-73. 2010
    ....
  25. ncbi Herbal medicines as diuretics: a review of the scientific evidence
    C I Wright
    Nutrition, Nutrition and Health Enhancement, Unilever Food and Health Research Institute, Olivier van Noortlaan 120, PO Box 114, 3130 AC, Vlaardingen, The Netherlands
    J Ethnopharmacol 114:1-31. 2007
    ..e., hypertension). One class of clinical medicines used to lower blood pressure are known as diuretics and work by increasing the excretion of urine from the body as well as the amount of sodium in urine...
  26. ncbi Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension
    John D Bisognano
    Department of Internal Medicine, Cardiology Division, University of Rochester Medical Center, New York 14642 8679, USA
    Vasc Health Risk Manag 3:579-85. 2007
    ..DHPs), angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs) added to diuretics or beta-blockers...
  27. ncbi Attenuated renal excretion in response to thiazide diuretics in Gitelman's syndrome: a case report
    Chung-Ho Yeum
    Department of Internal Medicine, Cheju National University Medical School, Jeju, Korea
    J Korean Med Sci 17:567-70. 2002
    ..The administration of thiazide diuretics may induce a subnormal increase of urinary Na+ and Cl- excretion in patients with Gitelman's syndrome, ..
  28. ncbi Pediatric idiopathic intracranial hypertension
    Lubaina M Rangwala
    Neuro ophthalmology Services of the Children s Hospital of Philadelphia, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Surv Ophthalmol 52:597-617. 2007
    ....
  29. ncbi Effect of sesame oil on diuretics or Beta-blockers in the modulation of blood pressure, anthropometry, lipid profile, and redox status
    D Sankar
    Department of Biotechnology, Aarupadai Veedu Institute of Technology, Vinayaka Mission s Research Foundation University, Paiyanoor 603104, Chennai, Tamilnadu, India
    Yale J Biol Med 79:19-26. 2006
    ..investigate the effect of sesame oil in hypertensive patients who were on antihypertensive therapy either with diuretics (hydrochlorothiazide) or Beta-blockers (atenolol)...
  30. ncbi Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care
    Peter Bramlage
    Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany
    BMC Cardiovasc Disord 8:30. 2008
    ..For example, diuretics and betablockers worsen glucose metabolism, hence the starting point of the current subanalysis of the CHILI (..
  31. ncbi Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy
    Gerd Bönner
    MEDIAN Kliniken, Bad Krozingen, Germany
    Blood Press Suppl 2:22-30. 2008
    ..To evaluate the efficacy and tolerability of candesartan cilexetil 32 mg in combination with hydrochlorothiazide (HCT) 12.5 mg or 25 mg in hypertensive patients not optimally controlled with candesartan monotherapy...
  32. ncbi Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide
    Lars Rejnmark
    Department of Endocrinology and Metabolism C, Aarhus Sygehus, Aarhus University Hospital, Aarhus, Denmark
    J Bone Miner Res 21:163-70. 2006
    To study effects of loop diuretics on bone, 87 women were randomized to 1 year of treatment with bumetanide or placebo. Compared with placebo, bumetanide decreased BMD by 2% at the total hip and by 1.4% at the whole body...
  33. ncbi Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics
    John M Costello
    Division of Cardiac Intensive Care, Department of Cardiology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
    Pediatr Crit Care Med 7:28-33. 2006
    ..INTERVENTIONS: Fenoldopam infusion for inadequate urine output despite conventional diuretics. MEASUREMENTS: Demographics, diagnostic information, and surgical procedures were recorded...
  34. ncbi Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
    Toshio Ogihara
    Osaka University Graduate School of Medicine, Osaka, Japan
    Hypertens Res 32:163-7. 2009
    ..Safety and tolerability will also be investigated. A total of more than 4000 patients were recruited and will be followed up for at least 3 years...
  35. ncbi Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites
    Georgios Kalambokis
    Department of Internal Medicine, Medical School of Ioannina, 45110 Ioannina, Greece
    Nephrol Dial Transplant 20:1623-9. 2005
    ..with renal dysfunction in cirrhotic patients with ascites, and in turn prevents the use of high doses of diuretics. Furthermore, ample evidence suggests that octreotide can inhibit the activation of the renin-aldosterone axis...
  36. ncbi Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure
    Kamala P Tamirisa
    Department of Internal Medicine, Women's L3623-0271, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA
    Am Heart J 148:971-8. 2004
    ..insufficiency had lower baseline body weight and higher baseline serum creatinine, required higher doses of loop diuretics, and were more likely to be treated with thiazide diuretics than controls...
  37. ncbi Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene
    Khalid Hussain
    London Centre for Paediatric Endocrinology and Metabolism, Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, University College and Great Ormond Street Hospital for Children NHS Trust, 30 Guilford Street, London WC1N 1EH, UK
    J Pediatr 146:706-8. 2005
    ..This mutation resulted in a nearly complete absence of immunoreactive protein and a decrease in fibroblast SCHAD activity...
  38. ncbi Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis
    Sandeep C Pingle
    Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois 62702, USA
    J Biol Chem 279:43157-67. 2004
    Osmotic diuretics are used successfully to alleviate acute tubular necrosis (ATN) produced by chemotherapeutic agents and aminoglycoside antibiotics...
  39. ncbi Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension
    Toshihiko Ishimitsu
    Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University, Mibu, Tochigi, Japan
    Hypertens Res 32:962-8. 2009
    ..These properties may provide cardiovascular protection in addition to the hypotensive effect...
  40. ncbi Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Mahboob Rahman
    Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals of Cleveland, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA
    Arch Intern Med 165:936-46. 2005
    ..Participants assigned to receive amlodipine had a higher GFR than those assigned to receive chlorthalidone, but rates of development of ESRD were not different between the groups...
  41. ncbi Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
    M R Lakshman
    Lipid Research Laboratory, Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
    Arch Intern Med 159:551-8. 1999
    ..Concern based on the reported short-term adverse effects of antihypertensive agents on plasma lipid and lipoprotein profiles (PLPPs) has complicated the therapy for hypertension...
  42. ncbi Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance
    Marco Metra
    Section on Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Italy
    Eur J Heart Fail 10:188-95. 2008
    ..Renal function is a powerful prognostic variable in patients with heart failure (HF). Hospitalisations for acute HF (AHF) may be associated with further worsening of renal function (WRF)...
  43. ncbi Potassium-sparing diuretics
    J D Horisberger
    Yale University School of Medicine, Department of Physiology, New Haven, Conn
    Ren Physiol 10:198-220. 1987
    Amiloride, triamterene, and the spirolactones are potassium-sparing diuretics which act on the distal parts of the nephron, from the late distal tubule to the collecting duct...
  44. ncbi Adverse prognostic significance of new diabetes in treated hypertensive subjects
    Paolo Verdecchia
    Dipartimento Malattie Cardiovascolari, Universita di Perugia, Ospedale R Silvestrini S Andrea delle Fratte 06122 Perugia, Italy
    Hypertension 43:963-9. 2004
    ..In treated hypertensive subjects, occurrence of new diabetes portends a risk for subsequent cardiovascular disease that is not dissimilar from that of previously known diabetes...
  45. ncbi A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure
    Ali Ahmed
    University of Alabama at Birmingham, and Veterans Affairs Medical Center, Birmingham, 1530 3rd Avenue South, CH19 219, Birmingham, Alabama 35294 2041, USA
    Int J Cardiol 125:246-53. 2008
    Non-potassium-sparing diuretics may increase mortality and hospitalizations in heart failure patients...
  46. ncbi [IQWIG Preliminary Report: Diuretics are the best antihypertensives. How does it go on with the high blood pressure therapy? (interview)]
    Peter Sawicki
    MMW Fortschr Med 149:6-8. 2007
  47. ncbi Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide
    Steven G Chrysant
    Oklahoma Cardiovascular and Hypertension Center, University of Oklahoma, 5850 W Wilshire Boulevard, Oklahoma City, OK 73132, USA
    Am J Hypertens 17:252-9. 2004
    ..The purpose of this study was to assess the efficacy and safety of the angiotensin II receptor blocker olmesartan medoxomil in combination with hydrochlorothiazide (HCTZ)...
  48. ncbi Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion
    Natarajan Aravindan
    Division of Cardiothoracic Anesthesia and Critical Care Medicine, Duke University, Durham, North Carolina, USA
    Ren Fail 28:25-35. 2006
    Loop diuretics are known to affect renal hemodynamics and possibly gene transcription, but the specific effect of furosemide on renal angiogenesis gene expression after acute ischemia is not known...
  49. ncbi Ethanol modulates the VR-1 variant amiloride-insensitive salt taste receptor. I. Effect on TRC volume and Na+ flux
    Vijay Lyall
    Department of Physiology, Division of Nephrology, Virginia Commonwealth University, Richmond, VA 23298, USA
    J Gen Physiol 125:569-85. 2005
    ..We conclude that in the presence of mineral salts, ethanol modulates the Bz-insensitive VR-1 variant salt taste receptor...
  50. ncbi Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B
    Bjorn Dahlof
    Department of Medicine, Sahlgrenska University Hospital Ostra, SE 416 85 Goteborg, Sweden
    Lancet 366:895-906. 2005
    ..of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics and beta blockers used...
  51. ncbi Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States
    Bimal V Patel
    MedImpact Healthcare Systems, Inc, San Diego, CA 92131, USA
    J Clin Hypertens (Greenwich) 9:692-700. 2007
    ..angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), beta-blockers (BBs), or diuretics were followed for 1 year (N=242,882). A higher proportion of ARB patients (51...
  52. ncbi Loop diuretics for patients with acute renal failure: helpful or harmful?
    Norbert Lameire
    JAMA 288:2599-601. 2002
  53. ncbi Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
    Stevo Julius
    University of Michigan, Ann Arbor, USA
    Lancet 363:2022-31. 2004
    ....
  54. ncbi Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors
    Tord Juhlin
    Department of Cardiology, , Malm, Sweden
    Eur J Heart Fail 7:1049-56. 2005
    ..This impairment is observed both with and without activation of the renin-angiotensin system and ACE-inhibitor treatment but is more pronounced after pre-treatment...
  55. ncbi Diuretics in the LIFE study
    Johji Kato
    Lancet 364:413; author reply 413-4. 2004
  56. ncbi Diuretics and mortality in acute renal failure
    Shigehiko Uchino
    Department of Intensive Care, Austin and Repatriation Medical Centre, Melbourne, Australia
    Crit Care Med 32:1669-77. 2004
    OBJECTIVE: According to recent research, diuretics may increase mortality in acute renal failure patients. The administration of diuretics in such patients has been discouraged...
  57. ncbi Ethanol modulates the VR-1 variant amiloride-insensitive salt taste receptor. II. Effect on chorda tympani salt responses
    Vijay Lyall
    Department of Physiology, Division of Nephrology, Virginia Commonwealth University, Richmond, VA 23298, USA
    J Gen Physiol 125:587-600. 2005
    ..VR-1 KO mice demonstrated no Bz-insensitive CT response to NaCl and no sensitivity to ethanol. We conclude that ethanol increases salt taste sensitivity by its direct action on the Bz-insensitive VR-1 variant salt taste receptor...
  58. ncbi Persistence with treatment in newly treated middle-aged patients with essential hypertension
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Quebec, Canada
    Ann Pharmacother 39:1401-8. 2005
    ..Surveys have shown that hypertension has been diagnosed in many patients but remains uncontrolled. One factor may be the lack of persistence to treatment...
  59. ncbi Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project
    L Niskanen
    Department of Medicine, University of Kuopio, Kuopio, Finland
    Diabetes Care 24:2091-6. 2001
    ..One planned subanalysis of the CAPPP was to evaluate the outcome in the diabetic patient group...
  60. ncbi Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone
    B Waeber
    Division of Clinical Pathophysiology and Medical Teaching, University Hospital, Lausanne, Switzerland
    J Hypertens 19:2097-104. 2001
    ....
  61. ncbi Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics
    M Motro
    Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel
    Hypertension 37:1410-3. 2001
    ..Using this method, our objective was to determine whether administration of nifedipine once daily in lieu of diuretics in high-risk hypertensive patients will arrest or slow down the progression of coronary artery calcification...
  62. ncbi Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial
    P Gentilini
    Institute of Internal Medicine, University of Florence School of Medicine, Italy
    J Hepatol 30:639-45. 1999
    ..We investigated whether intravascular volume expansion with albumin exert beneficial effects in cirrhosis with ascites...
  63. ncbi Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension
    S Oparil
    University of Alabama at Birmingham, Community Health Sciences, USA
    Am J Cardiol 87:721-6. 2001
    ..In conclusion, losartan/ HCTZ, alone or as part of a regimen with other standard antihypertensive agents, is effective and well tolerated in the treatment of patients with severe hypertension...
  64. ncbi Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
    G L Bakris
    Hypertensive Diseases Unit, Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Kidney Int 73:1303-9. 2008
    ..The dissociation between reductions in blood pressure and albuminuria may be related to factors other than blood pressure...
  65. ncbi [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus]
    Gyorgy Jermendy
    Bajcsy Zsilinszky Kórház III Belgyógyászati Osztály, Budapest
    Orv Hetil 145:949-56. 2004
    ..It is reasonable to initiate antihypertensive therapy primarily with a low dose combination of two agents in diabetic patients with hypertension...
  66. ncbi Combination therapy as first-line treatment for hypertension
    Irene Gavras
    Hypertension and Atherosclerosis Section, Boston University School of Medicine, 715 Albany Street, W508, Boston, MA 02118, USA
    Curr Hypertens Rep 6:267-72. 2004
    ....
  67. ncbi Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
    Joseph L Izzo
    State University of New York at Buffalo, Buffalo, NY 14215, USA
    Med Clin North Am 88:1257-71. 2004
    ....
  68. ncbi [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension]
    Li hua Zhai
    Department of Geriatrics, Shenzhen People s Hospital, Second Affiliated Hospital of Medical College, Jinan University, Shenzhen 518020, China
    Zhong Nan Da Xue Xue Bao Yi Xue Ban 30:719-22, 725. 2005
    ..To determine the therapeutic status and rate of reaching target blood pressure in elderly isolated systolic hypertension (EISH) patients who were hospitalized and to discuss the rationality of the drug therapy...
  69. ncbi [Medical treatment of hypertension--what treatment for what patients?]
    W Zidek
    Medizinischen Klinik IV Charité, Universitatsmedizin Berlin
    MMW Fortschr Med 146:31-4. 2004
    ..Resistance to therapy should prompt consideration of a number of causes, in particular noncompliance on the part of the patient...
  70. ncbi [Hypertension in patients with heart failure]
    Noboru Takekoshi
    Department of Cardiology, Kanazawa Medical University
    Nippon Rinsho 62:478-83. 2004
  71. ncbi [Control of blood pressure in prevention of hypertensive end-organ damage]
    Makiko Kido
    Department of Nephrology and Endocrinology, University of Tokyo School of Medicine
    Nippon Rinsho 62:389-93. 2004
  72. ncbi [Exercise in arterial hypertension]
    Hans-Georg Predel
    ,
    Herz 31:525-30. 2006
    ....
  73. ncbi Treatment of isolated systolic hypertension
    Gordon S Stokes
    Curr Hypertens Rep 8:377-83. 2006
    ..Treatment of ISH with diuretics, calcium channel blockers (CCBs), and angiotensin II inhibitors is effective in reducing systolic blood pressure,..
  74. ncbi The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects
    H Knauf
    Department of Medicine 1, St Berward Krankenhaus, Hildesheim, Germany
    Eur J Clin Pharmacol 62:885-92. 2006
    Thiazide diuretics are known to induce a transient fall of the glomerular filtration rate (GFR), which, in turn, reduces tubular Na(+) load. This tubuloglomerular feedback (TGF) curtails the natriuretic effect of this class of diuretics...
  75. ncbi Long-term safety of antihypertensive therapy
    Ehud Grossman
    Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Prog Cardiovasc Dis 49:16-25. 2006
    ..Despite the concern that has been raised regarding the long-term safety of some antihypertensive agents, it is clear that lowering BP is safe and beneficial...
  76. ncbi The ASCOT trial: a closer look
    Norman M Kaplan
    J Hypertens 24:211-4. 2006
  77. ncbi Modern antihypertensive therapy: a report from the 22nd annual meeting of the American Society of Hypertension
    X Rabasseda
    Prous Science Medical Information Department
    Timely Top Med Cardiovasc Dis 11:E17. 2007
  78. ncbi [Therapeutical strategies in hypertensive patients presenting heart failure symptoms]
    Christian Ebner
    II Interne Abteilung mit Kardiologie und Angiologie und Intensivstation, A ö Krankenhaus der Elisabethinen Linz, Linz, Osterreich
    Wien Med Wochenschr 154:8-14. 2004
    ..In progressive heart failure the use of diuretics is necessary and effective especially when fluid overload exists...
  79. ncbi Antihypertensive drugs and arterial stiffness
    Azra Mahmud
    Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland
    Expert Rev Cardiovasc Ther 1:65-78. 2003
    ..There are clear differences in the effects of antihypertensive drugs on these parameters and stiffness is becoming a therapeutic target in its own right...
  80. ncbi [Drug treatment of hypertension in hemodialysed patients]
    T Hannedouche
    Service de Nephrologie, Hopitaux Universitaires de Strasbourg, 67091 Strasbourg Cedex, France
    Nephrol Ther 3:S185-90. 2007
    ..On a practical ground, prescription will be driven by pharmacokinetics considerations and mostly according to specific indications pertinent to cardiovascular complications associated with hypertension...
  81. ncbi [Kidney and hypertension--evidence based medicine]
    Naoyuki Nakao
    Nippon Naika Gakkai Zasshi 93:1639-45. 2004
  82. ncbi Management of hypertension in patients with CKD: differences between primary and tertiary care settings
    Roberto Minutolo
    Department of Nephrology, Second University of Naples, Naples, Italy
    Am J Kidney Dis 46:18-25. 2005
    ..We compared hypertension management in patients with CKD followed up in PC and nephrology tertiary care (TC)...
  83. ncbi Rate and determinants of 10-year persistence with antihypertensive drugs
    Boris Lg Van Wijk
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, The Netherlands
    J Hypertens 23:2101-7. 2005
    ..52-2.84; 40-59 years: (reference), > or = 60 years: OR 0.69; 95% CI 0.54-0.89]. More patients who started with diuretics (reference) and beta blockers (OR 1.15; 95% CI 0.87-1...
  84. ncbi [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with bitherapy]
    T Tarrade
    IPSEN, Paris
    Arch Mal Coeur Vaiss 82:103-8. 1989
    ..Altogether, cicletanine proved to be effective and well tolerated when administered in combination with other antihypertensive drugs belonging to three main therapeutic classes...
  85. ncbi [Intervention studies on elderly hypertensive patients in Japan]
    Fumio Saito
    Department of Cardiology, Surugadai Nihon University Hospital
    Nippon Rinsho 63:1078-85. 2005
    ..in elderly hypertensive patients has been shown by the clinical intervention studies in western countries, using diuretics, beta-blockers, Ca antagonist, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers...
  86. ncbi [Management of elderly hypertensive individuals with hyperlipidemia]
    Koichi Kozaki
    Department of Geriatric Medicine, Kyorin University School of Medicine
    Nippon Rinsho 63:1061-6. 2005
    ..system inhibitors and calcium channel blockers would be the first choices, and the combination therapy with diuretics or alpha-blockers would be the next choice...
  87. ncbi [Heart failure in hypertension in the elderly]
    Shinji Seto
    Department of Cardiovascular Medicine, Course of Medical and Dental Sciences, Graduate School of Biomedical Sciences, Nagasaki University
    Nippon Rinsho 63:1041-6. 2005
    ..control by angiotensin-converting enzyme inhibitors and angiotensin-II receptor antagonists along with low-doses diuretics as first-line therapy is recommended...
  88. ncbi [Old or new antihypertensives--which are better?]
    J Schrader
    St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 147:36-7, 39-40. 2005
    ..calcium antagonists, ACE-inhibitors and angiotensin 1 receptor blockers) together with the classical agents (diuretics and beta blockers) are recognized as equally justifiable as the five agents of first choice in the treatment of ..
  89. ncbi Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil
    M Saito
    Department of Pharmacy, National Hospital Organization Osaka Medical Center, Japan
    J Clin Pharm Ther 30:603-10. 2005
    ....
  90. ncbi [The treatment of arterial hypertension: new trials--new approaches]
    Iu A Karpov
    Cardiology Research Complex, 121552 Moscow, Russia
    Kardiologiia 43:87-90. 2003
  91. ncbi Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group
    I Os
    Department of Medicine, Ullevaal University Hospital, Oslo, Norway
    Am J Hypertens 10:899-904. 1997
    ..019); there was a trend toward more patients achieving target diastolic BP (<90 mm Hg, P = .053). No clinically important differences in safety and tolerability were observed...
  92. ncbi Hypertension-related morbidity and mortality in African Americans--why we need to do better
    Keith C Ferdinand
    Heartbeats Life Center, Xavier University College of Pharmacy, New Orleans, LA, USA
    J Clin Hypertens (Greenwich) 8:21-30. 2006
    ..When given as monotherapy, diuretics and calcium channel blockers may be relatively more effective in lowering blood pressure in African Americans ..
  93. ncbi [Hypertension therapy in practice test. Calcium antagonist receives good marks]
    M Keck
    Fachklinik fur Herz- und Kreislaufkrankheiten Drei-Burgen-Klinik, , Ebernburg
    MMW Fortschr Med 147:51. 2005
  94. ncbi The role of combination therapy in the treatment of hypertension
    M Moser
    Yale University School of Medicine, New Haven, Connecticut, USA
    Am J Hypertens 11:73S-78S; discussion 95S-100S. 1998
    ..Many different combinations of diuretics and beta-blockers, angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists, as ..
  95. ncbi Association between cardiovascular outcomes and antihypertensive drug treatment in older women
    Sylvia Wassertheil-Smoller
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    JAMA 292:2849-59. 2004
    ..However, many patients with hypertension require treatment with more than 1 drug class to achieve blood pressure control. The relative benefits or risks of 2-drug-class combinations are not well known...
  96. ncbi Drug treatment of essential hypertension: the case for initial combination therapy
    L Welsh
    Department of Clinical Pharmacology, GKT School of Medicine (Cardiovascular Division, King's College London, Guy's Hospital Campus, London, UK
    Int J Clin Pract 58:956-63. 2004
    ....
  97. ncbi The importance of blood pressure control
    Sarah C Jarvis
    Richford Gate Medical Practice, Richford Street, London, UK
    Prof Nurse 20:48. 2004
  98. ncbi Cardiovascular outcomes and antihypertensive drug treatment in older women
    Michael Bursztyn
    JAMA 293:1588; author reply 1588-9. 2005
  99. ncbi Novel combinations in the treatment of hypertension
    D A Sica
    Division of Nephrology, Virginia Commonwealth University Health System, Richmond, VA, USA
    Minerva Urol Nefrol 57:129-39. 2005
    ..Such drug combinations include within class switching of diuretics, combining a thiazide-type diuretic with a calcium-channel blocker, utilizing 2 calcium-channel blockers from ..
  100. ncbi [Recent intervention studies with antihypertensive drugs and their influence on guidelines]
    Karl Heinz Rahn
    Medizinische Klinik und Poliklinik D, Universitatsklinikum, Muenster
    Med Klin (Munich) 98:771-5. 2003
    ..b>Diuretics, beta-blockers, calcium antagonists, angiotensin-converting enyzme (ACE) inhibitors, and angiotensin I (AT(1)) ..
  101. ncbi Hypertension: just the facts
    Kathy Sharp
    Blue Ridge Medical Specialists, Bristol, TN, USA
    Clin J Oncol Nurs 10:727-9. 2006

Research Grants86

  1. CELLULAR CALCIUM TRANSPORT IN URINARY EPITHELIA
    Peter Friedman; Fiscal Year: 2003
    ..We will: 1) Test the hypothesis that thiazide diuretics can inhibit Na+/Ca2+ exchange; and 2) Characterize the stimulatory effects of PTH on Na+/Ca2+ exchange...
  2. Hypertension Pharmacogenetics
    Julie Johnson; Fiscal Year: 2006
    ..of verapamil, and will significantly further our understanding of the pharmacogenetics of p-blockers, thiazide diuretics, and ACE inhibitors...
  3. RISK FACTORS FOR VERTEBRAL FRACTURE AND BONE LOSS
    Douglas Kiel; Fiscal Year: 1993
    ..for this change in BMD will include weight, physical activity (leisure), caffeine, smoking, alcohol, thiazide diuretics, testosterone levels, dietary calcium, 25 hydroxy-vitamin D levels and thyroid hormone replacement and hormone ..
  4. Pharmacogenetics and Cardiovascular Events
    Bruce Psaty; Fiscal Year: 2006
    ..cardiovascular drugs: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, all classes of diuretics, alpha blockers, beta-blockers, central alpha agonists, calcium antagonists, and estrogens...
  5. REGULATION OF KIDNEY-SPECIFIC GENE EXPRESSION
    Peter Igarashi; Fiscal Year: 1999
    ..the thick ascending limb of the loop of Henle and represents the site of action of the clinically important loop diuretics furosemide and bumetanide. Importantly, expression of Nkcc2 transcripts is only observed in the kidney...
  6. A Family Partnership Intervention for Heart Failure
    Sandra Dunbar; Fiscal Year: 2009
    ..urinary sodium), medication adherence to HF drugs including angiotensin converting enzyme inhibitors and diuretics (Medication Event Monitoring System), heart failure severity (brain natriuretic peptide levels), functional ..
  7. REGULATION OF KAPPA OPIOID RECEPTORS
    Lee Yuan Liu Chen; Fiscal Year: 2002
    ..Kappa agonists may be useful as analgesics, water diuretics and antipruritic agents...
  8. Cellular Pharmacology of Kappa Opioid Receptor
    Lee Yuan Liu Chen; Fiscal Year: 2007
    ..effects, including analgesia, dysphoria and water diuresis and kappa agonists may be useful as analgesics, water diuretics and antipruritic drugs...
  9. Combined Computational and Wet Lab Screening for Drugs Tested via OATs
    Sanjay K Nigam; Fiscal Year: 2010
    ..kidney, liver) of many common drugs (eg. antibiotics, antivirals, chemotherapeutics, NSAIDs, antihypertensives, diuretics)...
  10. CHARACTERIZATION OF INTESTINAL ABSORPTION OF VITAMIN B1
    HAMID SAID; Fiscal Year: 2003
    ..renal disease patients, the elderly, in inborn errors of thiamine metabolism, and in long-term users of diuretics. Humans and other mammals can not synthesize thiamine, and thus, must obtain the vitamin from exogenous sources ..
  11. Uric Acid and Hypertension in African-Americans
    Richard Johnson; Fiscal Year: 2007
    Thiazide diuretics are associated with many metabolic side effects including hyperuricemia, gout, insulin resistance, and hyperlipidemia. These very conditions are already highly prevalent in African-Americans...
  12. Treatment of Calcium Nephrolithiasis Sodium Thiosulfate
    John Asplin; Fiscal Year: 2006
    ..for calcium nephrolithiasis that have been proven effective in prospective placebo controlled trials, thiazide diuretics, potassium citrate salts, and allopurinol...